Search Results - "Sutton, Harold G"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    STAT1 pathway mediates amplification of metastatic potential and resistance to therapy by Khodarev, Nikolai N, Roach, Paul, Pitroda, Sean P, Golden, Daniel W, Bhayani, Mihir, Shao, Michael Y, Darga, Thomas E, Beveridge, Mara G, Sood, Ravi F, Sutton, Harold G, Beckett, Michael A, Mauceri, Helena J, Posner, Mitchell C, Weichselbaum, Ralph R

    Published in PloS one (08-06-2009)
    “…Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constitutively…”
    Get full text
    Journal Article
  3. 3

    Tumor endothelial inflammation predicts clinical outcome in diverse human cancers by Pitroda, Sean P, Zhou, Tong, Sweis, Randy F, Filippo, Matthew, Labay, Edwardine, Beckett, Michael A, Mauceri, Helena J, Liang, Hua, Darga, Thomas E, Perakis, Samantha, Khan, Sajid A, Sutton, Harold G, Zhang, Wei, Khodarev, Nikolai N, Garcia, Joe G N, Weichselbaum, Ralph R

    Published in PloS one (04-10-2012)
    “…Vascular endothelial cells contribute to the pathogenesis of numerous human diseases by actively regulating the stromal inflammatory response; however, little…”
    Get full text
    Journal Article
  4. 4

    HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation by Efimova, Elena V, Ricco, Natalia, Labay, Edwardine, Mauceri, Helena J, Flor, Amy C, Ramamurthy, Aishwarya, Sutton, Harold G, Weichselbaum, Ralph R, Kron, Stephen J

    Published in Molecular cancer therapeutics (01-02-2018)
    “…Despite significant advances in combinations of radiotherapy and chemotherapy, altered fractionation schedules and image-guided radiotherapy, many cancer…”
    Get full text
    Journal Article
  5. 5

    A Survivin-Associated Adaptive Response in Radiation Therapy by GRDINA, David J, MURLEY, Jeffrey S, MILLER, Richard C, MAUCERI, Helena J, SUTTON, Harold G, JIAN JIAN LI, WOLOSCHAK, Gayle E, WEICHSELBAUM, Ralph R

    Published in Cancer research (Chicago, Ill.) (15-07-2013)
    “…Adaptive responses can be induced in cells by very low doses of ionizing radiation resulting in an enhanced resistance to much larger exposures. The inhibitor…”
    Get full text
    Journal Article
  6. 6

    Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation by Barreto-Andrade, Juan Camilo, Efimova, Elena V, Mauceri, Helena J, Beckett, Michael A, Sutton, Harold G, Darga, Thomas E, Vokes, Everett E, Posner, Mitchell C, Kron, Stephen J, Weichselbaum, Ralph R

    Published in Molecular cancer therapeutics (01-07-2011)
    “…Radiation therapy remains a promising modality for curative treatment of localized prostate cancer, but dose-limiting toxicities significantly limit its…”
    Get full text
    Journal Article
  7. 7

    Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers by Labay, Edwardine, Mauceri, Helena J, Efimova, Elena V, Flor, Amy C, Sutton, Harold G, Kron, Stephen J, Weichselbaum, Ralph R

    Published in Oncotarget (07-06-2016)
    “…Radiation therapy remains a significant therapeutic modality in the treatment of cancer. An attractive strategy would be to enhance the benefits of ionizing…”
    Get full text
    Journal Article
  8. 8

    A Manganese Superoxide Dismutase (SOD2)-Mediated Adaptive Response by Grdina, David J., Murley, Jeffrey S., Miller, Richard C., Mauceri, Helena J., Sutton, Harold G., Thirman, Michael J., Li, Jian Jian, Woloschak, Gayle E., Weichselbaum, Ralph R.

    Published in Radiation research (01-02-2013)
    “…Very low doses of ionizing radiation, 5 to 100 mGy, can induce adaptive responses characterized by elevation in cell survival and reduction in micronuclei…”
    Get full text
    Journal Article
  9. 9

    Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer by MA UCERI, Helena J, SUTTON, Harold G, DARGA, Thomas E, KOCHERGINSKY, Masha, KOCHANSKI, Joel, WEICHSELBAUM, Ralph R, VOKES, Everett E

    Published in Oncology reports (01-05-2012)
    “…Signaling pathways that activate mTOR (mammalian target of rapamycin) are altered in many human cancers and these alterations are associated with prognosis and…”
    Get full text
    Journal Article
  10. 10

    Abstract 67: A novel survivin-mediated adaptive response induced by very low dose imaging-level exposures and radiation therapy by Murley, Jeffrey S., Miller, Richard C., Mauceri, Helena J., Sutton, Harold G., Weichselbaum, Ralph R., Grdina, David J.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Exposure of cells to a very low dose of ionizing radiation can induce an enhanced resistance or adaptive response to a subsequent larger radiation…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The transfacial approach for combined anterior craniofacial tumor ablation by Panje, W R, Dohrmann, 3rd, G J, Pitcock, J K, Scher, N, Weichselbaum, R R, Sutton, Jr, H G, Vokes, E, Moss, J

    “…The transfacial approach to the anterior cranial fossa for tumor removal provides for excellent surgical exposure, improved postoperative appearance, and a…”
    Get more information
    Journal Article
  14. 14

    Computer-aided geometric reconstruction of Fletcher-Suit source positions by Li, S, Pelizzari, C A, Reft, C, Sutton, H G, Chen, G T

    Published in Medical physics (Lancaster) (01-07-1994)
    “…A computer-aided method for reconstruction of the source positions of a Fletcher-Suit applicator has been developed. The tandem source positions are determined…”
    Get more information
    Journal Article
  15. 15

    A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer by Vokes, E E, Panje, W R, Mick, R, Kozloff, M F, Moran, W J, Sutton, H G, Goldman, M D, Tybor, A G, Weichselbaum, R R

    Published in Cancer (15-07-1990)
    “…Two regimens of neoadjuvant chemotherapy for previously untreated patients with locally advanced head and neck cancer were compared with the goal of…”
    Get more information
    Journal Article
  16. 16

    Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy by Vijayakumar, S, Quadri, S F, Karrison, T G, Trinidad, C O, Chan, S K, Halpern, H J, Rubin, S J, Sutton, H G

    Published in Radiology (01-07-1992)
    “…The serum half-life of prostate-specific antigen (PSA) after radical prostatectomy is about 3 days; to the authors' knowledge, the PSA half-life during…”
    Get more information
    Journal Article
  17. 17

    Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer by Vokes, E E, Haraf, D J, Weichselbaum, R R, McEvilly, J M, Sutton, H G, Panje, W R

    Published in Seminars in oncology (01-08-1992)
    “…Concomitant chemoradiotherapy has resulted in small increases in disease-free or overall survival for patients with advanced head and neck cancer when…”
    Get more information
    Journal Article
  18. 18

    Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas by Rotmensch, J, Rubin, S J, Sutton, H G, Javaheri, G, Halpern, H J, Schwartz, J L, Stewart, M, Weichselbaum, R R, Herbst, A L

    Published in Gynecologic oncology (01-02-1990)
    “…A therapeutic alternative to exenteration for large locally advanced vulvar carcinoma involving the rectum, anus, or vagina is the use of preoperative…”
    Get more information
    Journal Article
  19. 19

    Late effects of adjuvant radiotherapy for breast cancer by Ferguson, D J, Sutton, Jr, H G, Dawson, P J

    Published in Cancer (01-12-1984)
    “…Complications requiring in-hospital treatment were observed in 24 of 221 consecutively treated patients (11%) who were followed from 8 to 42 years after…”
    Get more information
    Journal Article